UNSPSC 85816331: Introduction of recombinant human-activated protein c into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of recombinant human-activated protein c into peripheral vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E03316

UNSPSC 85816331 Introduction of recombinant human-activated protein c into peripheral vein, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code describes a highly specialized pharmaceutical intervention—the intravenous administration of recombinant human-activated protein c, a hemostasis modulator used in critical care settings for severe sepsis or acute conditions. However, the recent opportunities block contains no solicitations matching this clinical service or pharmaceutical product category; state and local buyers are not currently procuring this specific intervention through coded procurement channels.

Recent state and local activity tagged to this code consists of telehealth urgent care services, general medical services contracting, nursing home operations, occupational health services, and other broad healthcare delivery arrangements that bear no relationship to recombinant protein administration. The mismatch between the code's nominal scope and the posted opportunities suggests either miscoding at the state or local level or that the code is rarely used for actual procurement. Businesses pursuing contracts for pharmaceutical products, critical care services, or blood component therapies should confirm UNSPSC alignment through direct engagement with issuing agencies rather than relying on this code's recent activity to inform strategy.